Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case

Author： Vázquez Emma Gutiérrez de Mesa Martín Juan Angel Jiménez

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.12, Iss.3, 2006-04, pp. : 229-236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Innovative capabilities and strategic alliances: Who is gaining what in the pharmaceutical industry?

By Ohba Marisa Figueiredo Paulo N

Journal of Commercial Biotechnology, Vol. 13, Iss. 4, 2007-08 ,pp. : 273-282

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Editorial: Yin, yang and the biopharmaceutical industry

By Miller Henry I

Journal of Commercial Biotechnology, Vol. 9, Iss. 4, 2003-06 ,pp. : 283-285

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Estimating production technical efficiency for the US biopharmaceutical industry

By Lin Yi-Hsing

International Journal of Biotechnology, Vol. 12, Iss. 3, 2012-11 ,pp. : 184-197

Inderscience Publishers

Access to resources Recommend Favorite

Riposte: FDA response to ‘Yin, yang and the biopharmaceutical industry’

By Rosenberg Amy S

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 36-39

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Innovation in the Spanish food and beverage industry: an integrated approach

By Lopez Nuria Montes-Peon J. Manuel Vazquez-Ordas Camilo

International Journal of Biotechnology, Vol. 5, Iss. 3-4, 2004-05 ,pp. : 311-333

Inderscience Publishers

Access to resources Recommend Favorite